Theramer^® Technology

Rimon Therapeutics is the Theramer^® Company. Theramers^® are medical polymers that have biological activity in and of themselves, without the use of drugs.

Theramers^® provide:

• Drug-like activities
• Device timelines
• Versatile chemistry

Core Theramer^® Technologies:

• MI Theramer^® - inhibits the activity of matrix metalloproteases (MMPs), a ubiquitous group of enzymes that are implicated in many conditions in which tissue is weakened or destroyed
• AM Theramer^® - a thermoplastic that kills gram +ve and gram -ve bacteria without harming mammalian cells
• Angiogenic Theramer^® - induces new blood vessel development (angiogenesis) in wounds or other ischemic tissue
• ThermaGel^® - a polymer that changes from a liquid to a strong gel reversibly around body temperature